Jun 8, 2020 Roth Capital Partners Acts as Lead Manager for Adaptimmune Therapeutics plc (Nasdaq: ADAP) in its $259.3 Million Follow-On Roth Capital Partners
Jun 5, 2020 Roth Capital Partners acts as Lead Manager for Sequans Communications S.A. (NYSE: SQNS) in its $25 Million Follow-On Roth Capital Partners
Jun 2, 2020 Roth Capital Partners acts as Lead Manager for Sequans Communications S.A. (NYSE: SQNS) in its $25 Million Follow-On Roth Capital Partners
May 26, 2020 Roth Capital Partners Acts as Co-Manager for Axcella Health (Nasdaq: AXLA) in its $60.1 Million Follow-On Roth Capital Partners
May 15, 2020 Roth Capital Partners Acts as Co-Manager for Compass Diversified Holdings (NYSE: CODI) in its $88 million Follow-On Roth Capital Partners
May 14, 2020 Roth Capital Partners Acts as Sole Book-Running Manager for Delcath Systems, Inc. (NASDAQ: DCTH) in its $22 Million Follow-On Roth Capital Partners
May 7, 2020 Roth Capital Partners Acts as Sole Placement Agent for Tellurian, Inc. (NASDAQ: TELL) in its $56 Million Registered Direct Note Offering Roth Capital Partners
May 6, 2020 Roth Capital Partners Acts as Sole Placement Agent for Immunic, Inc. (Nasdaq: IMUX) in its $15 Million Registered Direct Roth Capital Partners
May 5, 2020 Roth Capital Partners Acts as Lead Placement Agent for Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC) In its $20 Million Follow-On Roth Capital Partners
May 4, 2020 Roth Capital Partners Acts as Co-Manager for Arcturus Therapeutics Holdings, Inc. (NASDAQ: ARCT) in its $80.5 Million Follow-On Roth Capital Partners